Results
|
1.
|
|
|
2.
|
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors. MedStar authors:
Year: 2021
Citation: - Breast Cancer Research & Treatment. 190(2):287-293, 2021 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ahles TA, Ahn J, Bethea TN, Carroll JE, Cohen HJ, Dilawari A, Graham DA, Jim HSL, Mandelblatt JS, McDonald B, Nakamura ZM, Patel SK, Rentscher KE, Root JC, Saykin AJ, Small BJ, Thinking and Living with Cancer Study, Tometich D, Van Dyk K, Zhai W, Zhou X
|
|
3.
|
Genomic profiling of breast cancer in African-American women using MammaPrint. MedStar authors:
- Boisvert, Marc E
- Herbolsheimer, Pia M
- Mete, Mihriye
- Nunes, Raquel
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 159(3):481-8, 2016 Oct
Institution:
- MedStar Health Research Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Bijelic L, Boisvert ME, Herbolsheimer P, Mete M, Nunes RA, Smith KL, Swain SM, Wray L
|
|
4.
|
Risk of cardiovascular adverse events from trastuzumab (Herceptin()) in elderly persons with breast cancer: a population-based study. MedStar authors:
Year: 2014
Citation: - Breast Cancer Research & Treatment. 144(1):163-70, 2014 Feb.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Barac A, Freedman AN, Fu AZ, Huang CY, Isaacs C, Potosky AL, Tsai HT, Warren JL
|
|
5.
|
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
Year: 2013
Citation: - Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
|
|
6.
|
|
|
7.
|
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors:
- Blackburn, Matthew J
- Lynce, Filipa
Year: 2018
Citation: - Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H
|
|
8.
|
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer. MedStar authors:
Year: 2018
Citation: - Breast Cancer Research & Treatment. 172(1):221-230, 2018 Nov.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Andrews DW, Anne' PR, Dicker AP, Ko K, McCall NS, Mehta M, Nowak-Choi K, Rese A, Shi W, Simone BA, Simone NL, Venkataraman C, Zhan T
|